Skip to main content

Advertisement

Log in

Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis

  • Original Paper
  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Bile acid-induced apoptosis plays an important role in the pathogenesis of cholestatic liver disease, and its prevention is of therapeutic interest. The aim of this study was to test whether the andrographolide limits the evolution of apoptosis in a murine model of bile duct ligation (BDL)-induced hepatic fibrosis. Male Sprague–Dawley rats were divided into four groups and hepatic apoptosis was induced by BDL for 2 weeks. The BDL animals were also treated with andrographolide (50, 100, and 200 mg/kg, i.p.) during the same time period. BDL-induced liver injury was associated with apoptosis and fibrosis, and the latter was significantly reduced in animals receiving andrographolide. The increase in serum alanine aminotransferase, asparate aminotransferase, tumor necrosis factor-α and IL-1β levels caused by BDL were also significantly reduced by treatment with andrographolide. Andrographolide decreased the intrahepatic protein levels of cannabinoid receptor 1 (CB1), Bax, and cytochrome c, along with of α-smooth muscle actin (α-SMA) and transforming growth factor-β (TGF-β), two markers of fibrogenesis. This effect was mediated by the inactivation of the c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK1/2) phosphorylation cascade, but it did not affect the p38 mitogen-activated protein kinase pathway. Additionally, andrographolide reduced the generation of hepatic lipid peroxidation and enhance senescence marker protein-30 levels to resist the hepatic oxidative stress in the presence of BDL. In conclusion, this study has identified AP as a potent protector against cholestasis-induced apoptosis in vivo. Its anti-apoptotic action largely relies on the inhibition of the oxidative stress pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ (2002) Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 123:1323–1330

    Article  CAS  PubMed  Google Scholar 

  2. Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9:347–351

    Article  CAS  PubMed  Google Scholar 

  3. Schiff ER, Pockros P, Schiffman ML, McHutchinson J, Gish R, Afdhal NH, Makhviladze M, Oltersdorf T, Shapiro DA (2004) Oral IDN-6556, an anti apoptotic caspase inhibitor lowers aminotransferases in HCV patients. J Hepatol 40:24

    Article  Google Scholar 

  4. Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ (2004) The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther 308:1191–1196

    Article  CAS  PubMed  Google Scholar 

  5. Xiao ZL, Chen Q, Biancani P, Behar J (2001) Abnormalities of gallbladder muscle associated with acute inflammation in guinea pigs. Am J Physiol Gastrointest Liver Physiol 281:G490–G497

    CAS  PubMed  Google Scholar 

  6. Hasanein P, Shahidi S, Komaki A, Mirazi N (2008) Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis. Eur J Pharmacol 591:132–135

    Article  CAS  PubMed  Google Scholar 

  7. Gabbay E, Avraham Y, Ilan Y, Israeli E, Berry EM (2005) Endocannabinoids and liver disease. Liver Int 25:921–926

    Article  CAS  PubMed  Google Scholar 

  8. Sánchez C, de Ceballos ML, Gomez del Pulgar T, Rueda D, Corbacho C, Velasco G, Galve-Roperh I, Huffman JW, Ramón y Cajal S, Guzmán M (2001) Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res 61:5784–5789

    PubMed  Google Scholar 

  9. McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, Nagarkatti PS, Nagarkatti M (2002) Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 100:627–634

    Article  CAS  PubMed  Google Scholar 

  10. Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G, Casellas P (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 312:637–641

    CAS  PubMed  Google Scholar 

  11. Derkinderen P, Ledent C, Parmentier M, Girault JA (2001) Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J Neurochem 77:957–960

    Article  CAS  PubMed  Google Scholar 

  12. Rueda D, Galve-Roperh I, Haro A, Guzman M (2000) The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol 58:814–820

    CAS  PubMed  Google Scholar 

  13. Anderson NL, Esquer-Blasco R, Richardson F, Foxworthy P, Eacho P (1996) The effects of peroxisome proliferators on protein abundances in mouse liver. Toxicol Appl Pharmacol 137:75–89

    Article  CAS  PubMed  Google Scholar 

  14. Fountoulakis M, de Vera MC, Crameri F, Boess F, Gasser R, Albertini S, Suter L (2002) Modulation of gene and protein expression by carbon tetrachloride in the rat liver. Toxicol Appl Pharmacol 183:71–80

    Article  CAS  PubMed  Google Scholar 

  15. Lee TY, Chang HH, Kuo JJ, Shen JJ (2009) Changes of hepatic proteome in bile duct ligated rats with hepatic fibrosis following treatment with Yin-Chen-Hao-Tang. Int J Mol Med 23:477–484

    CAS  PubMed  Google Scholar 

  16. Rajagopal S, Kumar RA, Deevi DS, Satyanarayana C, Rajagopalan R (2003) Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J Exp Ther Oncol 3:147–158

    Article  CAS  PubMed  Google Scholar 

  17. Gabrielian ES, Shukarian AK, Goukasova GI, Chandanian GL, Panossian AG, Wikman G, Wagner H (2002) A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Phytomedicine 9:589–597

    Article  CAS  PubMed  Google Scholar 

  18. Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, Wells K, Wenner CA, Standish LJ (2000) A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res 14:333–338

    Article  CAS  PubMed  Google Scholar 

  19. Shen YC, Chen CF, Chiou WF (2002) Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol 135:399–406

    Article  CAS  PubMed  Google Scholar 

  20. Singha PK, Roy S, Dey S (2007) Protective activity of andrographolide and arabinogalactan proteins from Andrographis paniculata Nees, against ethanol-induced toxicity in mice. J Ethnopharmacol 111:13–21

    Article  CAS  PubMed  Google Scholar 

  21. Lee TY, Chang HH, Chen JH, Hsueh ML, Kuo JJ (2007) Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats. J Ethnopharmacol 109:318–324

    Article  PubMed  Google Scholar 

  22. Lee TY, Chen FY, Chang HH, Lin HC (2009) The effect of capillarisin on glycochenodeoxycholic acid-induced apoptosis and heme oxygenase-1 in rat primary hepatocytes. Mol Cell Biochem 325:53–59

    Article  CAS  PubMed  Google Scholar 

  23. Lee TY, Mai LM, Wang GJ, Chiu JH, Lin YL, Lin HC (2003) Protective mechanism of salvia miltiorrhiza on carbon tetrachloride-induced acute hepatotoxicity in rats. J Pharmacol Sci 91:202–210

    Article  CAS  PubMed  Google Scholar 

  24. Lee TY, Chang HH, Wu MY, Lin HC (2007) Yin-Chen-Hao-Tang ameliorates obstruction-induced hepatic apoptosis in rats. J Pharm Pharmacol 59:583–590

    Article  CAS  PubMed  Google Scholar 

  25. Sokol RJ, Winklhofer-Roob BM, Devereaux MW, McKim JM Jr (1995) Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology 109:1249–1256

    Article  CAS  PubMed  Google Scholar 

  26. Cantürk NZ, Canturk Z, Utkan NZ, Yenisey C, Ozbilim G, Yildirir C, Yalman Y (1998) Cytoprotective effects of alpha tocopherol against liver injury induced by extrahepatic biliary obstruction. East Afr Med J 75:77–80

    PubMed  Google Scholar 

  27. Li J, Huang W, Zhang H, Wang X, Zhou H (2007) Synthesis of andrographolide derivatives and their TNF-alpha and IL-6 expression inhibitory activities. Bioorg Med Chem Lett 17:6891–6894

    Article  CAS  PubMed  Google Scholar 

  28. Abu-Ghefreh AA, Canatan H, Ezeamuzie CI (2009) In vitro and in vivo anti-inflammatory effects of andrographolide. Int Immunopharmacol 93:313–318

    Article  Google Scholar 

  29. Peres W, Tuñón MJ, Collado PS, Herrmann S, Marroni N, González-Gallego J (2000) The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction. J Hepatol 33:742–750

    Article  CAS  PubMed  Google Scholar 

  30. Ebrahimkhani MR, Sadeghipour H, Dehghani M, Kiani S, Payabvash S, Riazi K (2005) Homocysteine alterations in experimental cholestasis and its subsequent cirrhosis. Life Sci 76:2497–2512

    Article  CAS  PubMed  Google Scholar 

  31. Ip YT, Davis RJ (1998) Signal transduction by the c-Jun N-terminal kinase (JNK)—from inflammation to development. Curr Opin Cell Biol 10:205–219

    Article  CAS  PubMed  Google Scholar 

  32. Chen YR, Meyer CF, Tan TH (1996) Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J Biol Chem 271:631–634

    Article  CAS  PubMed  Google Scholar 

  33. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179–185

    Article  CAS  PubMed  Google Scholar 

  34. Roulston A, Reinhard C, Amiri P, Williams LT (1998) Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem 273:10232–10239

    Article  CAS  PubMed  Google Scholar 

  35. Ozaki I, Tani E, Ikemoto H, Kitagawa H, Fujikawa H (1999) Activation of stress-activated protein kinase/c-Jun NH2-terminal kinase and p38 kinase in calphostin C-induced apoptosis requires caspase-3 like proteases but is dispensable for cell death. J Biol Chem 274:5310–5317

    Article  CAS  PubMed  Google Scholar 

  36. Chen JH, Hsiao G, Lee AR, Wu CC, Yen MH (2004) Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway. Biochem Pharmacol 67:1337–1345

    Article  CAS  PubMed  Google Scholar 

  37. Pacher P, Gao B (2008) Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases. Am J Physiol Gastrointest Liver Physiol 294:G850–G854

    Article  CAS  PubMed  Google Scholar 

  38. Teixeira-Clerc F, Julien B, Grenard P, Tran VN, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S (2006) CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 12:671–676

    Article  CAS  PubMed  Google Scholar 

  39. Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM (2009) Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J Hepatol 51:528–534

    Article  CAS  PubMed  Google Scholar 

  40. Avraham Y, Zolotarev O, Grigoriadis NC, Poutahidis T, Magen I, Vorobiav L, Zimmer A, Ilan Y, Mechoulam R, Berry EM (2008) Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice. Am J Gastroenterol 103:3047–3056

    Article  CAS  PubMed  Google Scholar 

  41. Rajesh M, Pan H, Mukhopadhyay P, Bátkai S, Osei-Hyiaman D, Haskó G, Liaudet L, Gao B, Pacher P (2007) Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J Leukoc Biol 82:1382–1389

    Article  CAS  PubMed  Google Scholar 

  42. Mallat A, Teixeira-Clerc F, Deveaux V, Lotersztajn S (2007) Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases. Exp Opin Ther Targets 11:403–409

    Article  Google Scholar 

  43. Nollen EA, Morimoto RI (2002) Chaperoning signaling pathways: molecular chaperones as stress-sensing ‘heat shock’ proteins. J Cell Sci 115:2809–2816

    CAS  PubMed  Google Scholar 

  44. Rao RV, Peel A, Logvinova A, del Rio G, Hermel E, Yokota T, Goldsmith PC, Ellerby LM, Ellerby HM, Bredesen DE (2002) Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 514:122–128

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by grants from the National Science Council, Taipei, Taiwan, NSC97-2320-B-182-006-MY3 (H.H. Chang), and the research grant from the Chang Gung Memorial Hospital, CMRPD170111 (T.Y. Lee) and CMRPG 380811 (K.C. Lee).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hen-Hong Chang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, TY., Lee, KC. & Chang, HH. Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis. Apoptosis 15, 904–914 (2010). https://doi.org/10.1007/s10495-010-0502-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-010-0502-z

Keywords

Navigation